Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学CRC Immunotherapy/MSI

Axel Grothey

MD

🏢West Cancer Center🌐USA

Director, GI Cancer Research

85
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Axel Grothey has made pivotal contributions to colorectal cancer treatment including leading the CORRECT trial for regorafenib and advancing treatment sequencing strategies. His work on maintenance therapy and treatment duration has optimized patient outcomes across treatment lines. He is a key opinion leader in integrating immunotherapy with established CRC therapies.

Share:

🧪Research Fields 研究领域

Colorectal cancer
Anti-angiogenesis
Regorafenib
TAS-102
Treatment sequencing

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Axel Grothey 的研究动态

Follow Axel Grothey's research updates

留下邮箱,当我们发布与 Axel Grothey(West Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment